Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+1 year archive
Canadian Market INK weekly newsletter
+1 year archive
3 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you cancel with-in 30 days of first subscribing, we will refund your payment upon request. After cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Marketwired News Releases

Apr 25, 2018 16:05 ET
Robert A. Essner, former Chairman and Chief Executive of Wyeth, named Executive Chairman of Elucida Oncology, Inc.
ELUCIDA ONCOLOGY, INC®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small nanoparticle platform technology for the diagnosis and treatment of cancer, announced today that it has appointed Robert A....
Apr 25, 2018 16:05 ET
VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, May 8, 2018
VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2018 after the market close on Tuesday, May 8, 2018. The company will host a conference call beginning at 4:30...
Apr 25, 2018 12:51 ET
Bombardier Commercial Aircraft Presents Airline and Supplier Awards for Outstanding Performance in 2017
Bombardier has announced the names of thirteen airlines that are the recipients of the company's 2017 Airline Reliability Awards. The company also announced one recipient of the 2017 In-Service Supplier Top Achievement Recognition (STAR) Award.
Apr 25, 2018 12:04 ET
Tampa Technology Company UNATION Expands Event Discovery and Promotional Platform into Twelve Additional Cities
UNATION, a Tampa-based technology company focused on event discovery and event promotion, has expanded their business into twelve additional markets throughout the Southeast and Texas, including Miami, Key West, Orlando, Jacksonville, Atlanta,...
Apr 25, 2018 11:50 ET
Apr 25, 2018 11:41 ET
Bluegreen Vacations(TM) Expands Virtual Reality Capabilities With Launch of Second Bluegreen VR Experience in 2018
BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) ("BBX Capital"), announced that Bluegreen Vacations Corporation (NYSE: BXG), which is 90% owned by BBX Capital, issued the following release. About BBX Capital Corporation: BBX Capital Corporation...
Apr 25, 2018 11:25 ET
Nemaska Lithium Announces Closing of Subscription Receipt Financing With SoftBank Group
Nemaska Lithium Inc. ("Nemaska Lithium" or the "Corporation") (TSX: NMX)(OTCQX: NMKEF)(FRANKFURT: N0T) is pleased to announce that it has closed its previously announced private placement (the "Placement") of 88,460,446 subscription receipts (the "Receipts") at a price of CAD 1.12 per Receipt for aggregate gross proceeds of CAD 99,075,700, pursuant to the investment agreement (the "Investment Agreement") entered into with SoftBank Group Corp. ("SoftBank") on April 5, 2018.
Apr 25, 2018 11:25 ET
Nemaska Lithium Announces Closing of Subscription Receipt Financing With SoftBank Group
Nemaska Lithium Inc. ("Nemaska Lithium" or the "Corporation") (TSX:NMX)(OTCQX:NMKEF)(FRANKFURT:N0T) is pleased to announce that it has closed its previously announced private placement (the "Placement") of 88,460,446 subscription receipts...
Apr 25, 2018 08:30 ET
Midwest Energy Emissions Corp. Secures Additional Order With First International Customer in Canada
Midwest Energy Emissions Corp. (OTCQB: MEEC) ("ME2C" or the "Company"), a leader in mercury emissions control in North America, has secured another order from its previously announced Canadian customer to install its proprietary Sorbent Enhancement...
Apr 25, 2018 08:13 ET
Bombardier Wins Contract to Provide up to 175 FLEXITY Trams to Brussels Transportation Company
Rail technology leader Bombardier Transportation and the Brussels Intercommunal Transportation Company (STIB) have signed a framework agreement to supply up to 175 BOMBARDIER FLEXITY trams. The total amount of the framework contract is valued up to approximately 480 million euro ($586 million US). The first firm order under this framework contract, also signed on April 24, is for 60 FLEXITY trams and is valued at approximately 169 million euro ($206 million US). The contract signature follows an announcement made by STIB on February 5, selecting Bombardier Transportation as preferred bidder.
Apr 25, 2018 08:13 ET
Bombardier Wins Contract to Provide up to 175 FLEXITY Trams to Brussels Transportation Company
Rail technology leader Bombardier Transportation and the Brussels Intercommunal Transportation Company (STIB) have signed a framework agreement to supply up to 175 BOMBARDIER FLEXITY trams. The total amount of the framework contract is valued up...
Apr 25, 2018 08:00 ET
Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to its Board of Directors
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other diseases, announced today that Dr. Ann...
Apr 24, 2018 17:05 ET
Perma-Fix Announces Private Exchange Offer
Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the "Company") announced today that it has commenced an offer to all holders of the Series B Preferred Stock (the "Series B Preferred Stock") of East Tennessee Materials and Energy Corporation,...
Apr 24, 2018 15:36 ET
Bombardier and 3 Points Aviation Strengthening Parts Support for Q Series Aircraft Family
Bombardier Commercial Aircraft announced today that it has strengthened its parts support portfolio for Q Series aircraft by entering into a collaborative agreement with 3 Points Aviation. Under the agreement Bombardier provides engineering specifications to assist 3 Points Aviation gain Parts Manufacture Approvals (PMA) from aviation authorities. These approvals give Bombardier operators the choice to purchase OEM-produced parts or PMA parts manufactured by an authorised third party. This will improve the overall part availability for Bombardier's Q Series aircraft.
Apr 24, 2018 15:36 ET
Bombardier and 3 Points Aviation Strengthening Parts Support for Q Series Aircraft Family
Bombardier Commercial Aircraft announced today that it has strengthened its parts support portfolio for Q Series aircraft by entering into a collaborative agreement with 3 Points Aviation. Under the agreement Bombardier provides engineering...
Apr 24, 2018 13:40 ET
BBX Capital to Issue Financial Results for the First Quarter, 2018
BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB) announced today that the Company plans to release its financial results for the first quarter ended March 31, 2018, in a press release to be issued after market close on Monday, May 7, 2018. About...
Apr 24, 2018 08:30 ET
Moleculin Enters Agreement with BSP Pharmaceuticals for its Leukemia Drug Candidate
Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System...
Apr 24, 2018 08:00 ET
Diversified Gas & Oil Significantly Strengthens Management Capabilities
Diversified Gas & Oil PLC (AIM: DGOC) ("Diversified" and the "Company"), a U.S.-based acquirer and operator of oil and gas producing assets, is pleased to provide an update on the strengthening of its organizational structure following the...
Apr 24, 2018 08:00 ET
Tetra Bio-Pharma Signs Landmark Commercialization Term Sheet for its Lead Pharmaceutical Product, PPP001, in Israel
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP) (OTCQB: TBPMF), announced today that the Company has signed a first binding term sheet for the marketing and distribution of PPP001 in Israel with Kamada Ltd., a leading pharmaceutical company. The signing of a Definitive Distribution Agreement is expected to follow shortly. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription.
Apr 24, 2018 07:58 ET
Tetra Bio-Pharma Signs Landmark Commercialization Term Sheet for its Lead Pharmaceutical Product, PPP001, in Israel
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), announced today that the Company has signed a first binding term sheet for the marketing and distribution of PPP001 in Israel with Kamada Ltd., a leading...